Evidence map›Paper›PMID 26556275›Full record

Trial reportmBio2015

Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces.

Egija Zaura, Bernd W Brandt, M Joost Teixeira de Mattos, Mark J Buijs, Martien P M Caspers, Mamun-Ur Rashid, Andrej Weintraub, Carl Erik Nord, Ann Savell, Yanmin Hu and 6 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03068546 (Long Term Stability of Oral Microbiome Samples), which is not on this map. Cited by 256 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
256citing papers in PubMed, 6 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03068546 completednot on this mapstarted 2017, after this paper: background citation

Long Term Stability of Oral Microbiome Samples

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2017 to 2019Enrolled30ConditionsOral Microbiota, Long Term Sample Stability
3 · Its place in the literature

Who cites it

256 citing papers in PubMed, 6 syntheses or guidelines pooled it, 449 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Pooled it
  7. Trial
  8. Assessing the Impact ofNutrients · 2026
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

196 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Egija ZauraDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands e.zaura@acta.nl.
Bernd W BrandtDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands.
M Joost Teixeira de MattosSwammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
Mark J BuijsDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands.
Martien P M CaspersResearch Group Microbiology and Systems Biology, TNO Earth, Life and Social Sciences, Zeist, The Netherlands.
Mamun-Ur RashidDepartment of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Andrej WeintraubDepartment of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Carl Erik NordDepartment of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Ann SavellHelperby Therapeutics Limited, London, United Kingdom.
Yanmin HuHelperby Therapeutics Limited, London, United Kingdom.
Antony R CoatesHelperby Therapeutics Limited, London, United Kingdom.
Mike HubankGenetics and Genomic Medicine Programme, UCL Institute of Child Health, London, United Kingdom.
David A SprattDepartment of Microbial Diseases, UCL Eastman Dental Institute, London, United Kingdom.
Michael WilsonDepartment of Microbial Diseases, UCL Eastman Dental Institute, London, United Kingdom.
Bart J F KeijserResearch Group Microbiology and Systems Biology, TNO Earth, Life and Social Sciences, Zeist, The Netherlands.
Wim CrielaardDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands.
University of Amsterdam · NLHelperby Therapeutics (United Kingdom) · GBEastman Dental Hospital · GBKarolinska Institutet · SEAcademic Center for Dentistry Amsterdam · NLKarolinska University Hospital · SEUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledDue to the spread of resistance, antibiotic exposure receives increasing attention. Ecological consequences for the different niches of individual microbiomes are, however, largely ignored. Here, we report the effects of widely used antibiotics (clindamycin, ciprofloxacin, amoxicillin, and minocycline) with different modes of action on the ecology of both the gut and the oral microbiomes in 66 healthy adults from the United Kingdom and Sweden in a two-center randomized placebo-controlled clinical trial. Feces and saliva were collected at baseline, immediately after exposure, and 1, 2, 4, and 12 months after administration of antibiotics or placebo. Sequences of 16S rRNA gene amplicons from all samples and metagenomic shotgun sequences from selected baseline and post-antibiotic-treatment sample pairs were analyzed. Additionally, metagenomic predictions based on 16S rRNA gene amplicon data were performed using PICRUSt. The salivary microbiome was found to be significantly more robust, whereas the antibiotics negatively affected the fecal microbiome: in particular, health-associated butyrate-producing species became strongly underrepresented. Additionally, exposure to different antibiotics enriched genes associated with antibiotic resistance. In conclusion, healthy individuals, exposed to a single antibiotic treatment, undergo considerable microbial shifts and enrichment in antibiotic resistance in their feces, while their salivary microbiome composition remains unexpectedly stable. The health-related consequences for the gut microbiome should increase the awareness of the individual risks involved with antibiotic use, especially in a (diseased) population with an already dysregulated microbiome. On the other hand, understanding the mechanisms behind the resilience of the oral microbiome toward ecological collapse might prove useful in combating microbial dysbiosis elsewhere in the body. IMPORTANCE: Many health care professionals use antibiotic prophylaxis strategies to prevent infection after surgery. This practice is under debate since it enhances the spread of antibiotic resistance. Another important reason to avoid nonessential use of antibiotics, the impact on our microbiome, has hardly received attention. In this study, we assessed the impact of antibiotics on the human microbial ecology at two niches. We followed the oral and gut microbiomes in 66 individuals from before, immediately after, and up to 12 months after exposure to different antibiotic classes. The salivary microbiome recovered quickly and was surprisingly robust toward antibiotic-induced disturbance. The fecal microbiome was severely affected by most antibiotics: for months, health-associated butyrate-producing species became strongly underrepresented. Additionally, there was an enrichment of genes associated with antibiotic resistance. Clearly, even a single antibiotic treatment in healthy individuals contributes to the risk of resistance development and leads to long-lasting detrimental shifts in the gut microbiome.

Indexed as

Anti-Bacterial AgentsDNA, RibosomalFecesHealthy VolunteersHumansMicrobiotaPlacebosRNA, Ribosomal, 16SSalivaSequence Analysis, DNASwedenTime FactorsUnited KingdomAnti-Bacterial AgentsDNA, RibosomalPlacebosRNA, Ribosomal, 16S

Identifiers

PMID26556275
PMCPMC4659469
OpenAlexW2174506646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.